The impact of new drug launches on longevity : evidence from longitudinal disease-level data from 52 countries, 1982-2001
Year of publication: |
June 2003
|
---|---|
Authors: | Lichtenberg, Frank R. |
Institutions: | National Bureau of Economic Research (contributor) |
Publisher: |
Cambridge, Mass : National Bureau of Economic Research |
Subject: | Sterblichkeit | Mortality | Arzneimittel | Pharmaceuticals | Schätzung | Estimation | Innovation |
Extent: | 1 Online-Ressource |
---|---|
Series: | NBER working paper series ; no. w9754 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Mode of access: World Wide Web System requirements: Adobe [Acrobat] Reader required for PDF files Hardcopy version available to institutional subscribers. |
Other identifiers: | 10.3386/w9754 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Spurious correlation in estimation of the health production function : a note
Akkoyunlu, Sule, (2009)
-
The contribution of pharmaceutical innovation to longevity growth in Germany and France
Lichtenberg, Frank R., (2010)
-
Lichtenberg, Frank R., (2012)
- More ...
-
The Benefits and Costs of Newer Drugs : Evidence from the 1996 Medical Expenditure Panel Survey
Lichtenberg, Frank R., (2001)
-
The Allocation of Publicly-Funded Biomedical Research
Lichtenberg, Frank R., (1998)
-
Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
Lichtenberg, Frank R., (1998)
- More ...